{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:09:03Z","timestamp":1783544943475,"version":"3.55.0"},"reference-count":35,"publisher":"Pan African Medical Journal","funder":[{"name":"This work was supported by Servier, Suresnes, France. Servier had no role in this manuscript's intellectual content and writing."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PAMJ"],"abstract":"<jats:p>Introduction: hypertension is a leading cause of cardiovascular disease and mortality in Morocco, with many patients remaining uncontrolled on monotherapy. This study evaluated the effectiveness and safety of adding perindopril arginine to amlodipine for better blood pressure (BP) control among patients with hypertension in Morocco.\n\n \n\nMethods: this multicentre, prospective observational study enrolled 1,614 patients with hypertension who were previously uncontrolled on amlodipine monotherapy and were prescribed perindopril. Baseline characteristics, BP measurements, and adverse events were monitored over 90 days.\n\n \n\nResults: participants had a mean age of 63.1 \u00b1 11.2 years, with 66.5% being women. Significant BP reductions were observed from baseline to day 90: mean systolic BP decreased from 171.3 mmHg to 128.7 mmHg (mean difference: -42.6 mmHg, p&lt;0.0001) and mean diastolic BP from 92.4 mmHg to 74.6 mmHg (mean difference: -17.8 mmHg, p&lt;0.0001). BP control (&lt;140\/90 mmHg) increased from 60.0% of patients at day 30 to 91.3% at day 90 (p&lt;0.0001). Safety assessments indicated minimal adverse events, with incidence decreasing over the study period. By day 90, only 0.25% of participants reported adverse events, including hypotension (0.06%), fatigue (0.06%), and headaches (0.06%). No serious adverse events were reported.\n\n \n\nConclusion: Moroccan patients with hypertension treated with a combination of amlodipine and perindopril arginine showed a significant improvement in BP control and a favourable safety profile. This strategy presents a promising approach for managing hypertension in similar populations.<\/jats:p>","DOI":"10.11604\/pamj.2025.52.186.49213","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:38:47Z","timestamp":1769773127000},"source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of an amlodipine and perindopril arginine-based strategy for hypertension management in Morocco: a prospective observational study"],"prefix":"10.11604","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4746-7516","authenticated-orcid":false,"given":"Selma Siham","family":"El Khayat","sequence":"first","affiliation":[{"name":"Nephrology Department, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-4085","authenticated-orcid":false,"given":"El Ghali Mohamed","family":"Benouna","sequence":"additional","affiliation":[{"name":"Cardiology Department, Ibn Rochd University Hospital, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Maadjhou Mba","sequence":"additional","affiliation":[{"name":"Health of Population in Transition Research Group, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mbanya","sequence":"additional","affiliation":[{"name":"Health of Population in Transition Research Group, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-8653","authenticated-orcid":false,"given":"Jean Claude","family":"Mbanya","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4870","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Chadli S, Taqarort N, El Houate B, Oulkheir S. Epidemiological transition in Morocco (1960-2015). Med Sante Trop. 2018;28(2):201-205. PubMed | Google Scholar","DOI":"10.1684\/mst.2018.0800"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Elyamani R, Soulaymani A, Hami H. Epidemiology of Cardiovascular Diseases in Morocco: A Systematic Review. Rev Diabet Stud. 2021 Nov 1;17(2):57-67. PubMed | Google Scholar","DOI":"10.1900\/RDS.2021.17.57"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Raevschi E, Grib L, Penina O, Obreja G. Relationship between cardiovascular health status and attitudes towards responsibility for health. Folia Med (Plovdiv). 2022;64(2):327-332. PubMed | Google Scholar","DOI":"10.3897\/folmed.64.e63538"},{"key":"ref3","unstructured":"World Health Organisation. Guideline for the pharmacological treatment of hypertension in adults. 2021. Accessed 6th July, 2024."},{"key":"ref4","unstructured":"Haute Autorit\u00e9 de Sant\u00e9: transparency committee. 2009. Accessed 8th June, 2025."},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Mostafa S, Shabana H, Khalil F, Mancy IME, Zedan HA, Elmoursi A et al. Evaluation of the Safety and Efficacy of Dual Therapy Perindopril\/Amlodipine in the Management of Hypertension. A Systematic Review and Meta-Analysis. High Blood Press Cardiovasc Prev. 2022 Nov;29(6):565-576. PubMed | Google Scholar","DOI":"10.1007\/s40292-022-00544-3"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Elliott WJ, Whitmore J, Feldstein JD, Bakris GL. Efficacy and safety of perindopril arginine + amlodipine in hypertension. J Am Soc Hypertens. 2015 Apr;9(4):266-74. PubMed | Google Scholar","DOI":"10.1016\/j.jash.2015.01.012"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hammoudi-Bendib N, Manamani L, Ouabdesselam S, Ouamer DS, Ghemri S, Courouve L et al. Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Arterial Hypertension in Current Medical Practice in Algeria. Curr Hypertens Rev. 2021;17(1):75-82. PubMed | Google Scholar","DOI":"10.2174\/1573402116666200324144223"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Katsukunya JN, Soko ND, Naidoo J, Rayner B, Blom D, Sinxadi P et al. Pharmacogenomics of Hypertension in Africa: Paving the Way for a Pharmacogenetic-Based Approach for the Treatment of Hypertension in Africans. Int J Hypertens. 2023;2023:9919677. PubMed | Google Scholar","DOI":"10.1155\/2023\/9919677"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Owolabi P, Adam Y, Adebiyi E. Personalizing medicine in Africa: current state, progress and challenges. Front Genet. 2023;14:1233338. PubMed | Google Scholar","DOI":"10.3389\/fgene.2023.1233338"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Tsioufis K, Kreutz R, Sykara G, van Vugt J, Hassan T. Impact of single-pill combination therapy on adherence, blood pressure control, and clinical outcomes: a rapid evidence assessment of recent literature. J Hypertens. 2020;38(6):1016-1028. PubMed | Google Scholar","DOI":"10.1097\/HJH.0000000000002381"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Putignano D, Orlando V, Monetti VM, Piccinocchi G, Musazzi UM, Piccinocchi R et al. Fixed Versus Free Combinations Of Antihypertensive Drugs: Analyses Of Real-World Data Of Persistence With Therapy In Italy. Patient Prefer Adherence. 2019;13:1961-1969. PubMed | Google Scholar","DOI":"10.2147\/PPA.S225444"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis. Hypertension. 2021 Feb;77(2):692-705. PubMed | Google Scholar","DOI":"10.1161\/HYPERTENSIONAHA.120.15781"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Belayachi S, Boukhari FZ, Essayagh F, Terkiba O, Zohoun A, Essayagh M et al. Non-adherence to antihypertensive drugs and its risk factors among hypertensive patients, Marrakech, Morocco. PLOS Glob Public Health. 2024;4(8):e0002774. PubMed | Google Scholar","DOI":"10.1371\/journal.pgph.0002774"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Stergiou GS, Palatini P, Parati G, O\u00b4Brien E, Januszewicz A, Lurbe E et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293-1302. PubMed | Google Scholar","DOI":"10.1097\/HJH.0000000000002843"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Chang M, Wang J. Adaptive Superiority and Noninferiority Trial Design with Paired Binary Data. CRBS. 2015 Sept 7;5(2):52-60.","DOI":"10.3844\/amjbsp.2015.52.60"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016 Mar 5;387(10022):957-967. PubMed | Google Scholar","DOI":"10.1016\/S0140-6736(15)01225-8"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Prejbisz A, Dobrowolski P, Doroszko A, Filipiak KJ, Januszewicz A, Olszanecka A et al. Practical use of single pill combinations in the treatment of hypertension \u2014 an analysis focused on perindopril-based combinations. Arter Hypertens. 2023;27(3):113-132. Google Scholar","DOI":"10.5603\/ah.96726"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005 Sep;366(9489):895-906. PubMed | Google Scholar","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Gupta A, Whiteley WN, Godec T, Rostamian S, Ariti C, Mackay J et al. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial. Eur Heart J. 2024 Apr 1;45(13):1159-1169. PubMed | Google Scholar","DOI":"10.1093\/eurheartj\/ehad814"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Mancia G, Asmar R, Amodeo C, Mourad JJ, Taddei S, Gamba MA et al. Comparison of single-pill strategies first line in hypertension: perindopril\/amlodipine versus valsartan\/amlodipine. J Hypertens. 2015 Feb;33(2):401-11. PubMed | Google Scholar","DOI":"10.1097\/HJH.0000000000000409"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Dat TV, Tu VL, Thu LNA, Quang NNA, Binh V, Nga NTQ et al. Effectiveness of perindopril\/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review. Front Pharmacol. 2024 Feb 8;14:1156655. PubMed | Google Scholar","DOI":"10.3389\/fphar.2023.1156655"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Park S. Ideal Target Blood Pressure in Hypertension. Korean Circ J. 2019 Nov;49(11):1002-1009. PubMed | Google Scholar","DOI":"10.4070\/kcj.2019.0261"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Degli Esposti L, Perrone V, Veronesi C, Gambera M, Nati G, Perone F et al. Modifications in drug adherence after switch to fixed-dose combination of perindopril\/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study. Curr Med Res Opin. 2018 Sep;34(9):1571-1577. PubMed | Google Scholar","DOI":"10.1080\/03007995.2018.1433648"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Snyman JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, Konradi AO, Perrone V et al. A real-world analysis of outcomes and healthcare costs of patients on perindopril\/indapamide\/amlodipine single-pill vs. multiple-pill combination in Italy. J Hypertens. 2024 Jan 1;42(1):136-142. PubMed | Google Scholar","DOI":"10.1097\/HJH.0000000000003570"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Weisser B, Predel HG, Gillessen A, Hacke C, Vor dem Esche J, Rippin G et al. Single Pill Regimen Leads to Better Adherence and Clinical Outcome in Daily Practice in Patients Suffering from Hypertension and\/or Dyslipidemia: Results of a Meta-Analysis. High Blood Press Cardiovasc Prev. 2020 Apr;27(2):157-164. PubMed | Google Scholar","DOI":"10.1007\/s40292-020-00370-5"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007 Aug;120(8):713-9. PubMed | Google Scholar","DOI":"10.1016\/j.amjmed.2006.08.033"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Insani WN, Wei L, Abdulah R, Alfian SD, Ramadhani NA, Andhika R et al. Exploring the association of adverse drug reactions with medication adherence and quality of life among hypertensive patients: a cross-sectional study. Int J Clin Pharm. 2025;47(2):354-364. PubMed | Google Scholar","DOI":"10.1007\/s11096-024-01832-9"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Gebreyohannes EA, Bhagavathula AS, Abebe TB, Tefera YG, Abegaz TM. Adverse effects and non-adherence to antihypertensive medications in University of Gondar Comprehensive Specialized Hospital. Clin Hypertens. 2019;25:1. PubMed | Google Scholar","DOI":"10.1186\/s40885-018-0104-6"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"McIntyre H, Costa FV, D\u00fcsing R, Ambrosioni E, Gerth W. The role of losartan in cost-effective hypertension control. Curr Med Res Opin. 2002;18(3):139-145. PubMed | Google Scholar","DOI":"10.1185\/030079902125000499"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Fleig SV, Weger B, Haller H, Limbourg FP. Effectiveness of a Fixed-Dose, Single-Pill Combination of Perindopril and Amlodipine in Patients with Hypertension: A Non-Interventional Study. Adv Ther. 2018;35(3):353-366. PubMed | Google Scholar","DOI":"10.1007\/s12325-018-0675-3"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Dewi NPAR, Pandin MGR, Nursalam, Agustini NLPIB, Wahyuni NWS, Putra KAN. Analysis of self-care factors in hypertension patients in community settings. medRxiv. 2024;2024-12. Google Scholar","DOI":"10.1101\/2024.12.01.24318276"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Zehra SN, Anwar A, Kamran S, Jawaid H, Maheen S, Ariff M. Effect of hypertension duration on relationship between blood pressure and signs and symptoms in hypertensive patients:a cross sectional survey. Int J Res Med Sci. 2019;7(7):2588-2594. Google Scholar","DOI":"10.18203\/2320-6012.ijrms20192883"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Lopes S, Mesquita-Bastos J, Alves AJ, Ribeiro F. Exercise as a tool for hypertension and resistant hypertension management: current insights. Integr Blood Press Control. 2018;11:65-71. PubMed | Google Scholar","DOI":"10.2147\/IBPC.S136028"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Alefan Q, Huwari D, Alshogran OY, Jarrah MI. Factors affecting hypertensive patients' compliance with healthy lifestyle. Patient Prefer Adherence. 2019;13:577-585. PubMed | Google Scholar","DOI":"10.2147\/PPA.S198446"}],"container-title":["Pan African Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:38:52Z","timestamp":1769773132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/content\/article\/52\/186\/full\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":35,"URL":"https:\/\/doi.org\/10.11604\/pamj.2025.52.186.49213","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"article-number":"49213"}}